Physician profile
Ramon Alvarez
NPI 1063450310
$3,798.18
in general payments reported to CMS, 2019-2025
29 companies · $994 in 2025
The $994 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $538 · 2021: $368 · 2022: $423 · 2023: $58.83 · 2024: $600 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $956.04 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $447.99 | 2019-2021 | |
| Nevro Corp. | $398.79 | 2020-2024 | Senza |
| Globus Medical, INC. | $392.63 | 2025 | Senza |
| Zyla Life Sciences, INC. | $233.87 | 2019 | |
| Si-Bone, INC. | $178.13 | 2025 | |
| Abbvie INC. | $165.04 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.68 | 2025 | Relistor |
| Biodelivery Sciences International, INC. | $126.56 | 2019-2021 | |
| Boston Scientific Corporation | $107.62 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $91.04 | 2022 | |
| Pfizer INC. | $54.22 | 2019 | |
| Medtronic, INC. | $43.96 | 2025 | Inceptiv |
| Forte Bio-Pharma LLC | $42.23 | 2019 | |
| Ibsa Pharma INC. | $42.16 | 2020-2024 | Tirosint, Flector, Licart |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $42.04 | 2019 | |
| Grt US Holding, INC. | $38.40 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.45 | 2019 | |
| Horizon Therapeutics Plc | $34.36 | 2019-2022 | |
| Pacira Therapeutics, INC. | $33.58 | 2019-2020 | |
| Daiichi Sankyo INC. | $32.38 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.73 | 2025 | |
| Redhill Biopharma INC. | $24.83 | 2021 | |
| Tonix Medicines, INC. | $21.96 | 2025 | Tonmya |
| Stimwave Technologies Incorporated | $20.96 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.01 | 2023 | Seglentis |
| Hikma Pharmaceuticals USA | $13.84 | 2022 | |
| Allergan, INC. | $12.43 | 2019 | |
| Fidia Pharma USA INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.